Predictors of Mortality in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
作者： Pranab M. Barman , Pratima Sharma , Venkat Krishnamurthy , Jonathon Willatt , Heather McCurdy
DOI: 10.1007/S10620-014-3247-7
关键词:
摘要: Background/Aim Transarterial chemoembolization (TACE) is the recommended treatment for patients with Barcelona stage B hepatocellular carcinoma; however, community practice varies from these American Association Study of Liver Diseases guidelines. In this study, we sought to assess factors determining outcome after TACE and examine adherence
springer.com
sci-hub.se 参考文章(17)
H. SHEN, D. AGARWAL, R. QI, N. CHALASANI, S. LIANGPUNSAKUL, L. LUMENG, H. YOO, P. KWO, Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization Alimentary Pharmacology & Therapeutics. ,vol. 26, pp. 393- 400 ,(2007) , 10.1111/J.1365-2036.2007.03395.X
Giuseppe Cabibbo, Chiara Genco, Vito Di Marco, Marco Barbara, Marco Enea, Piero Parisi, Giuseppe Brancatelli, Piero Romano, Antonio Craxì, Calogero Cammà, Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 196- 204 ,(2011) , 10.1111/J.1365-2036.2011.04694.X
Jorge Marrero, Multidisciplinary management of hepatocellular carcinoma: where are we today? Seminars in Liver Disease. ,vol. 33, ,(2013) , 10.1055/S-0033-1333631
Josep M Llovet, Jordi Bruix, Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology. ,vol. 37, pp. 429- 442 ,(2003) , 10.1053/JHEP.2003.50047
M. Sherman, K. Burak, J. Maroun, P. Metrakos, J. J. Knox, R. P. Myers, M. Guindi, G. Porter, J. R. Kachura, P. Rasuli, S. Gill, P. Ghali, P. Chaudhury, J. Siddiqui, D. Valenti, A. Weiss, R. Wong, Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma Current Oncology. ,vol. 18, pp. 228- 240 ,(2011) , 10.3747/CO.V18I5.952
Ya-Ju Tsai, Chia-Yang Hsu, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Rheun-Chuan Lee, Jen-Huey Chiang, Teh-Ia Huo, Shou-Dong Lee, Early identification of poor responders to transarterial chemoembolization for hepatocellular carcinoma Hepatology International. ,vol. 5, pp. 975- 984 ,(2011) , 10.1007/S12072-011-9276-9
Augusto Villanueva, Virginia Hernandez-Gea, Josep M. Llovet, Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nature Reviews Gastroenterology & Hepatology. ,vol. 10, pp. 34- 42 ,(2013) , 10.1038/NRGASTRO.2012.199
Chung-Mau Lo, Henry Ngan, Wai-Kuen Tso, Chi-Leung Liu, Chi-Ming Lam, Ronnie Tung-Ping Poon, Sheung-Tat Fan, John Wong, Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. ,vol. 35, pp. 1164- 1171 ,(2002) , 10.1053/JHEP.2002.33156
Pratima Sharma, Sameer D. Saini, Latoya B. Kuhn, Joel H. Rubenstein, Darrell S. Pardi, Jorge A. Marrero, Philip S. Schoenfeld, Knowledge of Hepatocellular Carcinoma Screening Guidelines and Clinical Practices Among Gastroenterologists Digestive Diseases and Sciences. ,vol. 56, pp. 569- 577 ,(2011) , 10.1007/S10620-010-1453-5
Amit G Singal, Jorge A Marrero, Recent advances in the treatment of hepatocellular carcinoma Current Opinion in Gastroenterology. ,vol. 26, pp. 189- 195 ,(2010) , 10.1097/MOG.0B013E3283383CA5